13 research outputs found
Refractory Cases of Adult Onset Still's Disease Successfully Treated with TNF-Ξ± Blocker
Adult onset Still`s disease (AOSD) is a systemic inflammatory disorder of unknown etiology characterized by spiking fever, evanescent salmon-colored rash, polyarthritis and leukocytosis. The diagnosis of AOSD remains a challenge to clinicians and requires a high index of suspicion because of its rarity and nonspecific symptoms. Although the etiology and pathogenesis of AOSD is not elucidated clearly, the pathogenetic role of inflammatory cytokines, such as interleukin (IL)-6, IL-8, IL-18 and tumor necrosis factor (TNF)-Ξ± were suggested and the correlations of their levels with disease activity were also reported. These results raise a possibility that the blocking of these cytokines may provide a therapeutic benefit in controlling disease activity and relieving the symptoms of AOSD. Recently, we experienced two cases of AOSD, who were refractory to the treatment with high dose glucocorticoid and immunosuppressive agents. Both were treated with TNF- blockers and experienced remissions thereafter. These experiences might support the use of biologic agents in refractory AOSD.ope
Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis
OBJECTIVES: To determine whether osteopontin (OPN) is increased in patients with AS and to investigate its relationship to inflammatory disease activity and bone remodelling process.
METHODS: This cross-sectional study included 30 patients with AS and 23 age- and sex-matched healthy controls. We assessed clinical characteristics and laboratory parameters including the ESR, CRP, lipid profiles, the Bath AS disease activity index (BASDAI) and the Bath AS radiographic index (BASRI). To evaluate bone metabolism, we tested ALP, OCN and C-telopeptide of type I collagen (CTX-I). Plasma levels of OPN, TNF-alpha and IL-6 were measured by ELISA, and mRNA expression in peripheral blood mononuclear cells (PBMCs) was performed by RT-PCR. Changes in OPN level were also evaluated in eight patients after the treatment with a TNF-alpha blocker.
RESULTS: Patients with AS had significantly higher plasma OPN, TNF-alpha and IL-6 levels and more mRNA expression than healthy controls. Plasma OPN levels were correlated with serum ALP, OCN and CTX-I levels, but not with ESR, CRP, lipid profiles, BASDAI or BASRI. Treatment with a TNF-alpha blocker did not alter OPN levels, although it reduced the disease activity.
CONCLUSIONS: Patients with AS had higher levels of OPN compared with controls. The plasma OPN level was correlated with serum ALP, OCN and CTX-I levels, but not with disease activity in AS. OPN might be involved in bone remodelling rather than in inflammation in AS.ope
Longitudinal Myelitis in the Cervical Cord Presenting Weakness of the Lower Extremities, as an Initial Manifestation of SLE
Transverse myelitis is a rare and serious complication of systemic lupus erythematosus (SLE). Magnetic resonance imaging (MRI) shows cord swelling and increased signal intensity in T2-weighted images in a patient with transverse myelitis. We described a 45-year-old man presenting with weakness on the lower extremities without involvement of the upper extremities, as an initial manifestation of SLE. The lesion was involved continuous levels of the cervical spinal cord, a distinctive feature recently named `longitudinal myelitis`. His symptoms and signs responded well to the cyclophosphamide and methylprednisolone pulse therapies. So far, 10 cases of longitudinal myelitis have been reported in the world. But only 2 cases presented lower extremities weakness rather than upper extremities, in spite of cervical spine involvement. We report a patient with longitudinal myelitis in the cervical cord presenting weakness of the lower extremities as an initial manifestation of SLE with literature review.ope
Two Cases of Calcinosis Cutis Combined with Rheumatologic Disease
The calcinosis, dystrophic soft tissue calcification, occurs in damaged or devitalized tissues normal calcium/phosphorus metabolism. It is the subcutaneous tissues of connective tissues disease ??primarily systemic lupus erythematosus, scleroderma, or dermatomyositis ??and may involve a relatively localized area. The calcinotic accumulations may result in muscle atrophy, joint contractures, and skin ulceration complicated by recurrent episodes of local inflammation and infection. Calcinosis may be the source of both pain and disability in connective tissue disease patients. While various therapeutic modality have been used, no treatment has convincingly prevented or reduced calcinosis. We report two cases of calcinosis cutis combined with rheumatic disease.ope
Kikuchi-Fujimoto`s Disease with Adult Onset Still`s Disease
Kikuchi-Fujimoto`s disease (KFD), or histiocytic necrotizing lymphadenitis, is a rare benign and self-limiting disease. KFD are confused with systemic autoimmune disease as they present with localized lymphadenopathy, fever, fatigue, arthritis, leukopenia. Furthermore as KFD can occur associated with other autoimmune disease, we need to diagnose carefully. Here, we describe a case of 27-year-old female patient, diagnosed as KFD, who subsequently developed adult onset Still`s disesase (AOSD). As far as we know, this is the first case of KFD with AOSD in Korea.ope
A Case of Successful Treatments of Venous Leg Ulcers in Secondary Antiphospholipid Syndrome
Antiphospholipid syndrome is an autoimmune disorder characterized by recurrent arterial or venous thrombosis, and pregnancy loss. A 57-year-old woman was admitted for aggravation of both leg ulcers. Venogram showed chronic venous obstructions at both lower extremities, and chest x-ray and computed tomography revealed serositis in pericardium and pleura. The laboratory tests revealed pancytopenia, and positive tests for antinuclear antibody, anti-dsDNA antibody, lupus anticoagulant and anticardiolipin antibody, which led to a diagnosis of antiphospholipid syndrome secondary to systemic lupus erythematous. After medical treatments by anticoagulation and immunosuppression, and surgical managements including subtotal skin graft and local flap surgery, leg ulcers had been successfully treated without recurrence. Recognition of antiphospholipid syndrome as a cause of venous ulcer and the treatment plans including anticoagulation and surgical management is important in proper managementsope
κ°μ§μ±μ²μΆμΌμ λ§μ΄νμ‘λ¨ν΅κ΅¬μμ μ€μ€ν μ€ν°ν΄ mRNAμ λ°νκ³Ό μ§λ³ νμ±λμμ μ°κ΄μ±
Dept. of Medicine/μμ¬[νκΈ]μ°κ΅¬λ°°κ²½ λ° λͺ©μ : κ°μ§μ±μ²μΆμΌμ 골 κ°μμ ν¨κ» μλ‘μ΄ κ³¨ νμ±μ νΉμ§μΌλ‘ νλ λ§μ± μΌμ¦μ± μ§νμ΄λ€. κ·Έλ¬λ μμ§κΉμ§ κ·Έ λ³μΈμ΄ λͺ
νν λ°νμ Έ μμ§ μλ€. μ€μ€ν
μ€ν°ν΄μ 골μ¬νμ± κ³Όμ μ μ€μν μν μ ν λΏλ§ μλλΌ μΌμ¦μ± μ¬μ΄ν μΉ΄μΈμΌλ‘μ μμ©νλ€. μ΄ μ°κ΅¬μμλ κ°μ§μ±μ²μΆμΌ νμμ νμ‘ λ΄μ μ€μ€ν
μ€ν°ν΄μ λλμ λ§μ΄νμ‘λ¨ν΅κ΅¬μμ λ°νλλ μ€μ€ν
μ€ν°ν΄ mRNA μ λλ₯Ό μ‘°μ¬νμλ€. λν μ§λ³ νμ±λ λ° κ³¨ νμ±μ κ΄μ¬νλ νμ§μλ€κ³Όμ μκ΄ κ΄κ³λ₯Ό μμλ³΄κ³ , κ°μ§μ±μ²μΆμΌμμ λ°νμ΄ μ¦κ°λλ λ€λ₯Έ μΌμ¦μ± μ¬μ΄ν μΉ΄μΈλ€κ³Όμ μκ΄ κ΄κ³μ λνμ¬ μ‘°μ¬νμλ€.μ°κ΅¬μ¬λ£ λ° λ°©λ²: μ΄ μ°κ΅¬λ 20λͺ
μ κ°μ§μ±μ²μΆμΌ 20λͺ
μ 건κ°ν λμ‘°κ΅°μ λμμΌλ‘νμ¬ λ¨λ©΄μ‘°μ¬μ°κ΅¬λ‘ μ§νλμλ€. νμ² λ΄ μ€μ€ν
μ€ν°ν΄κ³Ό μ’
μκ΄΄μ¬μΈμ-μν, μΈν°λ£¨ν¨-6μ λλλ ν¨μλ©΄μμΈ‘μ λ²μ ν΅νμ¬ μΈ‘μ νμκ³ , λ§μ΄νμ‘λ¨ν΅κ΅¬μμ mRNAμ λ°ν μ λλ₯Ό μμ보기 μν΄ μμ μ¬ν¨μ-μ€ν©ν¨μμ°μλ°μμ μννμλ€. νμμ μμμ μΈ νΉμ§λ€μ μ‘°μ¬νκ³ , μ νꡬ침κ°μλμ C-λ°μλ¨λ°±, μμΉΌλ¦¬μ± ν¬μ€ννμ λ₯Ό μΈ‘μ νμμΌλ©° BASDAIμ BASRIλ₯Ό νκ°νμλ€. κ·Έλ¦¬κ³ μ΄λ€ νλͺ©λ€κ³Ό μ€μ€ν
μ€ν°ν΄κ³Όμ μ°κ΄μ±μ λνμ¬ μ‘°μ¬νμλ€.μ°κ΅¬ κ²°κ³Ό: νμ² μ€μ€ν
μ€ν°ν΄κ³Ό μ’
μκ΄΄μ¬μΈμ-μν, μΈν°λ£¨ν¨-6 λλλ κ°μ§μ±μ²μΆμΌ νμκ΅°μμ μ μ λμ‘°κ΅°μ λΉνμ¬ λͺ¨λ μ μνκ² λκ² μΈ‘μ λμλ€ (μ€μ€ν
μ€ν°ν΄; 76.92Β±16.60 ng/ml vs 26.00Β±7.23 ng/ml, p<0.01, μ’
μκ΄΄μ¬μΈμ-μν; 63.59Β±14.15 pg/ml vs 18.59Β±4.97 pg/ml, p<0.01, μΈν°λ£¨ν¨-6; 40.26Β±3.80 ng/ml vs 11.30Β±1.52 ng/ml, p<0.01). mRNAμ λ°ν μ λ λν μ€μ€ν
μ€ν°ν΄κ³Ό μ’
μκ΄΄μ¬μΈμ-μν, μΈν°λ£¨ν¨-6 λͺ¨λ μ μ λμ‘°κ΅°μ λΉνμ¬ κ°μ§μ±μ²μΆμΌ νμκ΅°μμ μ μν μ°¨μ΄λ₯Ό 보μ΄λ©° λκ² λνλ¬λ€ (μ€μ€ν
μ€ν°ν΄; 118.83Β±19.05 vs 82.64Β±17.28, p<0.01, μ’
μκ΄΄μ¬μΈμ-μν; 117.25Β±15.03 vs 77.23Β±22.37, p<0.01, μΈν°λ£¨ν¨-6; 128.24Β±16.97 vs 62.49Β±16.75, p<0.01). μ€μ€ν
μ€ν°ν΄ mRNAμ λ°ν μ λλ μ’
μκ΄΄μ¬μΈμ-μνμ μΈν°λ£¨ν¨-6 mRNAμ λ°νκ³Ό μ μν μκ΄κ΄κ³κ° μμλ€ (rho = 0.555, p<0.01; rho = 0.655, p<0.01). λν μ€μ€ν
μ€ν°ν΄ mRNAμ λ°ν μ λλ μ νꡬ침κ°μλ, C-λ°μλ¨λ°±, BASDAIμλ μ μν μκ΄κ΄κ³λ₯Ό λνλμΌλ (rho = 0.435, p = 0.03; rho = 0.388, p = 0.04; rho = 0.520, p<0.01), μμΉΌλ¦¬μ± ν¬μ€ννμ λ BASRIμλ ν΅κ³μ μ μμ±μ 보μ΄μ§ μμλ€.κ²°λ‘ : κ°μ§μ±μ²μΆμΌ νμκ΅°μ μ μ λμ‘°κ΅°μ λΉν΄ νμ² μ€μ€ν
μ€ν°ν΄ λλμ λ§μ΄νμ‘λ¨ν΅κ΅¬μμ μ€μ€ν
μ€ν°ν΄ mRNAμ λ°ν μ λκ° μ¦κ°λμ΄ μμλ€. κ°μ§μ±μ²μΆμΌμμ μ€μ€ν
μ€ν°ν΄μ mRNA λ°νμ μ’
μκ΄΄μ¬μΈμ-μν, μΈν°λ£¨ν¨-6 mRNAμ λ°ν λ° κ°μ§μ±μ²μΆμΌμμ μ§λ³νμ±λλ₯Ό λνλ΄λ νμ§μμΈ μ νꡬ침κ°μλ, C-λ°μλ¨λ°±, BASDAIμ μ μν μκ΄κ΄κ³λ₯Ό λνλλ€. κ²°λ‘ μ μΌλ‘ μ€μ€ν
μ€ν°ν΄μ κ°μ§μ±μ²μΆμΌμ νλμ±μ κ΄μ¬νλ μλ¬Όνμ νμ§μλ‘ μκ°λλ€.
[μλ¬Έ]Objective: Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown etiology that is characterized by new bone formation, syndesmophytes, as well as osteopenia. Osteopontin (OPN) plays an important role in the regulation of bone remodeling and acts as an inflammatory cytokine. In this study, we investigated the level of serum OPN protein and the expression of OPN mRNA in PBMC in patients with AS. We also assessed the association between the expression of OPN and disease activity or bone formation parameters, and the expression of other inflammatory cytokines that were increased in AS.Methods: This cross-sectional study included 20 patients with AS and 20 age and sex matched healthy controls. The serum levels of OPN, TNF-Ξ± and IL-6 were determined by ELISA, and the expression of their mRNA was performed by RT-PCR. We assessed clinical characteristics and laboratory parameters including ESR, CRP, alkaline phosphatase, BASDAI and BASRI, and evaluated their relationship to the expression of OPN.Results: When compared to controls, patients with AS had significantly higher mean serum OPN, TNF-Ξ± and IL-6 levels (OPN; 76.92Β±16.60 ng/ml vs 26.00Β±7.23 ng/ml, p<0.01, TNF-Ξ±; 63.59Β±14.15 pg/ml vs 18.59Β±4.97 pg/ml, p<0.01, IL-6; 40.26Β±3.80 ng/ml vs 11.30Β±1.52 ng/ml, p<0.01), as well as increased mRNA expression (OPN; 118.83Β±19.05 vs 82.64Β±17.28, p<0.01, TNF-Ξ±; 117.25Β±15.03 vs 77.23Β±22.37, p<0.01, IL-6; 128.24Β±16.97 vs 62.49Β±16.75, p<0.01). The expression of OPN mRNA was associated with the expression of TNF-Ξ± and IL-6 mRNA (rho = 0.555, p<0.01; rho = 0.655, p<0.01, respectively). The expression of OPN mRNA also had association with ESR, CRP and BASDAI (rho = 0.435, p = 0.03; rho = 0.388, p = 0.04; rho = 0.520, p<0.01, respectively), but no association with alkaline phosphatase and BASRI.Conclusion: Patients with AS had higher levels of serum OPN protein and the OPN mRNA expression in PBMC compared to controls. The expression of OPN mRNA was associated with other inflammatory cytokines, such as TNF-Ξ± and IL-6, which were increased in AS, as well as ESR, CRP and BASDAI, disease activity markers in AS.ope
Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model
Synovial angiogenesis plays an important role in the inflammation in rheumatoid arthritis (RA). Vascular endothelial growth factor (VEGF) is a key molecule in angiogenesis and binds to specific receptors, known as vascular endothelial growth factor receptor I (VEGF RI). In this study, we investigated the therapeutic efficacy of anti-VEGF RI antibody (Ab) on RA using a collagen-induced arthritis (CIA) mouse model. Twelve DBA/1 mice were divided into three groups. All mice except controls were injected with type II collagen. Mice in the anti-VEGF-RI-Ab-treated groups were injected on one posterior paw with 50 microg anti-VEGF RI Ab twice weekly for 3 weeks. Arthritis score and paw thickness were measured and histopathologic assessment of joint sections was performed by hematoxylin-eosin. The infiltration of CD45+ inflammatory cells and neovascularization were evaluated by immunohistochemical staining. Anti-VEGF RI Ab significantly attenuated the arthritis severity and histopathologic findings in the CIA mice model. The infiltration of CD45+ cells decreased in anti-VEGF-RI-Ab-treated joint tissues. Staining for CD31 revealed reduced synovial neovascularization after anti-VEGF RI Ab treatment. The data showing that in vivo administration of anti-VEGF RI Ab suppressed arthritis in established CIA mice suggest anti-VEGF RI Ab treatment may serve as a new therapeutic modality for RA.ope
Serum leptin levels correlate with interleukinβ6 levels and disease activity in patients with ankylosing spondylitis
OBJECTIVE:
To determine whether serum leptin levels are elevated in men with ankylosing spondylitis (AS) and whether the levels correlate with serum cytokine profiles and disease activity of AS.
METHODS:
Forty-two male patients with newly diagnosed AS were enrolled. Their Bath AS Disease Activity Index (BASDAI), body mass index (BMI), and acute phase reactants, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, were assessed. Serum leptin levels were determined using radioimmunoassay (RIA) and serum cytokine profiles, including tumour necrosis factor (TNF)-alpha, interleukin (IL)-6, and interferon (IFN)-gamma, were determined using enzyme-linked immunosorbent assay (ELISA). These results were compared with those from 42 age-matched healthy men. After a follow-up period of 31.0+/-20.1 months, clinical and biochemical variables were reassessed in the men with AS.
RESULTS:
At baseline, patients with AS had significantly elevated serum levels of leptin, leptin adjusted for BMI (leptin/BMI), TNFalpha, and IL-6, but not IFN-gamma, as compared to the controls. Serum leptin/BMI levels correlated well with IL-6 levels, and both leptin/BMI and IL-6 levels correlated well with BASDAI and CRP levels in patients with AS. The changes in leptin/BMI and IL-6 levels between the baseline and follow-up measurements correlated well with one another (p<0.05) and both correlated well with the changes in BASDAI (p<0.05).
CONCLUSION:
Serum leptin/BMI levels were increased and significantly associated with IL-6 levels and disease activity in men with AS, suggesting a possible role for leptin in the inflammatory reactions of AS.ope